Virilizing Adrenocortical Tumor: A Case Report

    May 2016 in “ Endocrine Abstracts ”
    Silvia Maraver-Selfa, Isabel Cornejo‐Pareja, Cristina Diaz-Perdigones, Isabel Mancha-Doblas, Francisco J. Tinahones
    Image of study
    TLDR The removal of the adrenal tumor improved the patient's symptoms and reduced androgen levels, indicating successful surgery.
    In 2016, a case study was conducted on a 31-year-old woman who had a history of hirsutism, acne, and androgenetic alopecia, symptoms of SAHA syndrome. She had a right adrenal mass, which was removed through adrenalectomy. The mass was a 6.8 cm, 120 g lesion, diagnosed as a corticoadrenal adenoma. Post-surgery, the patient began hydrocortisone replacement therapy and showed improvement, including spontaneous menstruation and weight loss. Biochemical tests showed a significant reduction in androgen levels. The study concluded that distinguishing between benign and malignant adrenocortical tumors (ACT) is challenging, even with anatomo-pathology diagnosis. The best indicator of malignancy is clinical evolution, and in this case, the rapid reduction of androgens post-surgery indicated surgical success.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 24 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Spironolactone or bicalutamide prescription

      in Treatment  4 upvotes 1 year ago
      The conversation is about someone seeking a doctor in the EU who prescribes spironolactone or bicalutamide for female pattern hair loss, as they are having difficulty finding treatment options beyond Minoxidil in Austria. They are asking for recommendations and are open to direct messages for assistance.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  36 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

    Similar Research

    6 / 1000+ results
      The SAHA Syndrome: Overview and Classification

      research The SAHA Syndrome: Overview and Classification

      70 citations, January 2000 in “Hormone Research in Paediatrics”
      SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.
      The Clinical Evaluation of Hirsutism

      research The Clinical Evaluation of Hirsutism

      67 citations, September 2008 in “Dermatologic therapy”
      Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.
      Acne as a Chronic Systemic Disease

      research Acne as a Chronic Systemic Disease

      71 citations, November 2013 in “Clinics in Dermatology”
      Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.